{
  "evidence": [
    {
      "variant": "SNCA A30P",
      "functional_evidence": {
        "step_1": {
          "judgment": "Yes",
          "notes": "The paper explicitly links Î±-synuclein (SNCA) dysfunction to Parkinson's disease (PD) pathogenesis via Lewy body formation and associates A30P with familial PD."
        },
        "step_2": {
          "judgment": "Yes",
          "notes": "The membrane binding assay directly evaluates SNCA function relevant to PD pathogenesis."
        },
        "step_3a": {
          "judgment": "Yes",
          "notes": "The study compares wild-type (Wt) and mutant SNCA (A30P) binding behaviors, fulfilling basic control requirements."
        },
        "step_3c": {
          "judgment": "No",
          "notes": "No explicit use of other clinically classified variants (e.g., P/LP or B/LB) as controls in the abstract."
        },
        "step_4b": {
          "judgment": "Yes",
          "notes": "Only 3 variants (A30P, A53T, E46K) are tested as controls, totaling <10."
        },
        "final_strength": "PS3_supporting"
      }
    },
    {
      "variant": "SNCA A53T",
      "functional_evidence": {
        "step_1": {
          "judgment": "Yes",
          "notes": "The paper links A53T to PD and examines its impact on SNCA function."
        },
        "step_2": {
          "judgment": "Yes",
          "notes": "Membrane binding assays are directly relevant to SNCA's role in PD."
        },
        "step_3a": {
          "judgment": "Yes",
          "notes": "Wild-type (Wt) and mutant SNCA (A53T) binding are compared."
        },
        "step_3c": {
          "judgment": "No",
          "notes": "No other variants are used as controls in the abstract."
        },
        "step_4b": {
          "judgment": "Yes",
          "notes": "Only 3 variants (A30P, A53T, E46K) are tested as controls, totaling <10."
        },
        "final_strength": "PS3_supporting"
      }
    },
    {
      "variant": "SNCA E46K",
      "functional_evidence": {
        "step_1": {
          "judgment": "Yes",
          "notes": "The paper associates E46K with PD and evaluates its functional impact."
        },
        "step_2": {
          "judgment": "Yes",
          "notes": "Membrane binding assays are relevant to SNCA's role in PD pathology."
        },
        "step_3a": {
          "judgment": "Yes",
          "notes": "Wild-type (Wt) and mutant SNCA (E46K) binding are compared."
        },
        "step_3c": {
          "judgment": "No",
          "notes": "No other variants are used as controls in the abstract."
        },
        "step_4b": {
          "judgment": "Yes",
          "notes": "Only 3 variants (A30P, A53T, E46K) are tested as controls, totaling <10."
        },
        "final_strength": "PS3_supporting"
      }
    }
  ]
}